from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0929/pstC2

LFCtreatmentdescriptionclass of inhibitor

-0.232

Amikacinug/mL Amikacintranslation

-2.259

Cap5-10ug/mL Capreomycintranslation

-1.546

Rox10-50 ug/mL Roxithromycintranslation

0.383

SM2-5 ug/mL Streptomycintranslation

0.263

Tet5-10 ug/mL Tetracyclinetranslation

0.145

Rif0.2-5ug/mL Rifampicintranscription

0.814

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.039

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.310

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.290

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.444

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.146

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.444

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.243

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.267

Nigericin50 uM Nigericinrespiration

-0.373

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

1.183

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.000

menadione6-10 ug/mL Menadionerespiration

-0.918

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.278

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.696

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.704

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.584

NRP_1Non-replicating persistence stage 1dosRassociated

1.310

Amp0.2mg/mL AmpicillincellWall

0.087

Cephalexin20-100 ug/mL CephalexincellWall

-0.204

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.130

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.083

EMB10-20 ug/mL EthambutolcellWall

0.195

Eta12-40 ug/mL EthionamidecellWall

-0.364

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.457

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.218

BZA0.12 mg/mL BenzamidearomaticAmides

-0.245

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.048

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.648

H2O24 mM hydrogen peroxideDNAdamaging

-0.430

Levo10 ug/mL LevofloxacinDNAdamaging

0.226

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.046

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.172

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.525

Antimycin12.5-50 ug/mL Antimycin A?

-0.096

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.300

PA_110-50 ug/mL Antitubercular compound PA-1?

0.020

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.793

PA8240.2-2 ug/mL PA-824?

0.552

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.389

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

2.053

Verapamil50 uM Verapamil?

-0.743

mercaptoethanol2 mM 2-Mercaptoethanol?

2.208

methoxatin10-20 ug/mL Methoxatin?